Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Jan 15, 2021; 13(1): 12-23
Published online Jan 15, 2021. doi: 10.4251/wjgo.v13.i1.12
Published online Jan 15, 2021. doi: 10.4251/wjgo.v13.i1.12
Table 1 Patient characteristics
Cases | Age in yr | Gender | BMI, kg/m2 | Tumor height from anorectal junction in cm | Clinical stage | CRT | Pathological stage | Tumor size in cm | Technique | Operation time in min | Blood loss in mL | POHS | Time to first flatus in d | Complications |
1 | 64 | F | 21.94 | 5.0 | T3N2b | Yes | ypT0N0 | 7.0 | taTME | 198 | 100 | 9 | 2 | N |
2 | 48 | M | 30.78 | 5.0 | T3N2b | Yes | ypT3N1b | 1.5 | taTME | 270 | 100 | 12 | 3 | N |
3 | 64 | M | 30.06 | 5.0 | T3N2b | Yes | ypT3N0 | 1.5 | taTME (Hartmann) | 364 | 100 | 9 | 2 | N |
4 | 67 | M | 25.24 | 6.0 | T3N1 | Yes | ypT2N1a | 2.0 | taTME | 270 | 100 | 11 | 2 | Fever |
5 | 57 | M | 27.11 | 5.0 | T3N2 | Yes | ypT2N0 | 2.0 | taTME | 392 | 100 | 9 | 3 | N |
6 | 66 | M | 20.44 | 3.0 | T3N+ | Yes | ypT2N0 | 1.0 | taTME | 262 | 50 | 9 | 2 | N |
7 | 45 | M | 26.67 | 4.0 | T3N0 | Yes | ypT3N0 | 1.2 | taTME | 317 | 200 | 8 | 2 | N |
8 | 38 | M | 25.82 | 3.0 | T3bN2a | Yes | ypT2N0 | 2.0 | taTME | 266 | 200 | 9 | 2 | N |
9 | 47 | M | 24.39 | 5.0 | T3N+ | Yes | ypT2N1 | 2.5 | taTME | 375 | 100 | 14 | 10 | Obstruction |
10 | 61 | M | 26.20 | 4.0 | T3N2b | Yes | ypT3N1a | 1.3 | taTME | 293 | 100 | 9 | 3 | N |
11 | 62 | M | 29.41 | 6.0 | T4aN+ | Yes | ypT3N2b | 2.0 | taTME | 337 | 100 | 10 | 2 | N |
12 | 72 | M | 36.37 | 3.0 | T4N+ | Yes | ypT0N1a | 0.5 | taTME | 405 | 200 | 12 | 2 | Fever |
13 | 65 | M | 24.0 | 7.0 | T3N+ | Yes | ypT3N1a | 2.0 | taTME | 290 | 100 | 7 | 2 | N |
14 | 51 | M | 25.76 | 2.0 | T3N2b | Yes | ypT1N1b | 2.0 | taTME | 364 | 200 | 9 | 2 | N |
15 | 55 | M | 23.66 | 8.0 | T3N+ | Yes | ypT3N0 | 4.0 | taTME | 400 | 100 | 10 | 2 | N |
16 | 30 | M | 26.17 | 3.0 | T3N0 | Yes | ypT0N0 | 0.0 | taTME | 283 | 100 | 10 | 2 | N |
17 | 61 | M | 26.99 | 5.0 | T2N2 | Yes | ypT2N0 | 1.5 | taTME | 245 | 50 | 7 | 2 | Fever |
18 | 49 | F | 26.34 | 2.0 | T3N+ | Yes | ypT2N0 | 1.1 | taTME | 226 | 100 | 7 | 2 | N |
19 | 58 | M | 20.96 | 2.0 | T3N+ | Yes | ypT3N0 | 1.0 | taTME | 342 | 200 | 10 | 2 | N |
20 | 60 | M | 26.90 | 5.0 | T3N1 | No | ypT3N0 | 5 | taTME | 271 | 100 | 7 | 2 | N |
21 | 71 | M | 25.3 | 5.0 | T3N1 | Yes | ypT2N0 | 0.5 | taTME | 310 | 100 | 8 | 2 | Anastomotic fracture |
22 | 69 | M | 23.9 | 3.0 | T3N2 | Yes | ypTIN0 | 1.5 | taTME | 317 | 50 | 8 | 2 | N |
23 | 39 | F | 24.2 | 4.0 | Neuroendocrine tumor G2 | No | Neuroendocrine tumor G2 | 1.0 | taTME | 235 | 50 | 12 | 2 | N |
24 | 59 | M | 23.39 | 4.0 | T3N+ | Yes | ypT2N0 | 1.0 | taTME | 266 | 50 | 8 | 2 | N |
Table 2 Low anterior resection syndrome questionnaire and scoring[16]
LARS Score: Scoring instructions |
Add the scores from each 5 answers to one final score. |
Do you ever have occasions when you cannot control your flatus (wind)? |
□ No, never |
□ Yes, less than once per week |
□ Yes, at least once per week |
Do you ever have any accidental leakage of liquid stool? |
□ No, never |
□ Yes, less than once per week |
□ Yes, at least once per week |
How often do you open your bowels? |
□ More than 7 times per day (24 h) |
□ 4-7 times per day (24 h) |
□ 1-3 times per day (24 h) |
□ Less than once per day (24 h) |
Do you ever have to open your bowels again within 1 hour of the last bowel opening? |
□ No, never |
□ Yes, less than once per week |
□ Yes, at least once per week |
Do you ever have such a strong urge to open your bowels that you have to rush to the toilet? |
□ No, never |
□ Yes, less than once per week |
□ Yes, at least once per week |
Total Score: |
Interpretation: |
0-20: No LARS |
21-29: Minor LARS |
30-42: Major LARS |
- Citation: Li YJ, Wang L, Sun TT, Wu AW. Laparoscopy-assisted transanal total mesorectal excision for lower rectal cancer: A feasible and innovative technique. World J Gastrointest Oncol 2021; 13(1): 12-23
- URL: https://www.wjgnet.com/1948-5204/full/v13/i1/12.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i1.12